| Literature DB >> 25281661 |
Koichi Matsuda1, Atsushi Takahashi2, Candace D Middlebrooks3, Wataru Obara4, Yasutomo Nasu5, Keiji Inoue6, Kenji Tamura6, Ichiro Yamasaki6, Yoshio Naya7, Chizu Tanikawa1, Ri Cui1, Jonine D Figueroa3, Debra T Silverman3, Nathaniel Rothman3, Mikio Namiki8, Yoshihiko Tomita9, Hiroyuki Nishiyama10, Kenjiro Kohri11, Takashi Deguchi12, Masayuki Nakagawa13, Masayoshi Yokoyama14, Tsuneharu Miki7, Hiromi Kumon5, Tomoaki Fujioka4, Ludmila Prokunina-Olsson3, Michiaki Kubo2, Yusuke Nakamura15, Taro Shuin6.
Abstract
Through genome-wide association analysis and an independent replication study using a total of 1131 bladder cancer cases and 12 558 non-cancer controls of Japanese populations, we identified a susceptibility locus on chromosome 15q24. SNP rs11543198 was associated with bladder cancer risk with odds ratio (OR) of 1.41 and P-value of 4.03 × 10(-9). Subgroup analysis revealed rs11543198 to have a stronger effect in male smokers with OR of 1.66. SNP rs8041357, which is in complete linkage disequilibrium (r(2) = 1) with rs11543198, was also associated with bladder cancer risk in Europeans (P = 0.045 for an additive and P = 0.025 for a recessive model), despite much lower minor allele frequency in Europeans (3.7%) compared with the Japanese (22.2%). Imputational analysis in this region suggested CYP1A2, which metabolizes tobacco-derived carcinogen, as a causative candidate gene. We also confirmed the association of previously reported loci, namely SLC14A1, APOBEC3A, PSCA and MYC, with bladder cancer. Our finding implies the crucial roles of genetic variations on the chemically associated development of bladder cancer.Entities:
Mesh:
Year: 2014 PMID: 25281661 PMCID: PMC4834880 DOI: 10.1093/hmg/ddu512
Source DB: PubMed Journal: Hum Mol Genet ISSN: 0964-6906 Impact factor: 6.150